Expand Document | Expand Chapter | Full TOC | Printable HTML version
Essential Drugs Monitor No. 017 (1988)
(1988)
Table of Contents
View the documentIntroduction
View the documentObjective
View the documentEthical criteria
View the documentApplicability and implementation of criteria
View the documentPromotion
View the documentAdvertising
View the documentMedical Representatives
View the documentFree samples of prescription drugs for promotional purposes
View the documentSymposia and other scientific meetings
View the documentPost-marketing scientific studies, surveillance and dissemination of information
View the documentPackaging and labelling
View the documentInformation for patients: package inserts, leaflets and booklets
View the documentPromotion of exported drugs
View the documentAppendix - Sample Drug Information Sheet
Open this folder and view contentsEDM-17 DRUG DISCUSSIONS AT THE 47TH WORLD HEALTH ASSEMBLY
Open this folder and view contentsRole of the Pharmacist
 

Symposia and other scientific meetings

22. Symposia are useful for disseminating information. The objective scientific content of such meetings should be paramount, and presentations by independent scientists and health professionals are helpful to this end. Their educational value may be enhanced if they are organized by scientific or professional bodies.

23. The fact of sponsorship by a pharmaceutical manufacturer or distributor should clearly be stated in advance, at the meeting and in any proceedings. The latter should accurately reflect the presentations and discussions. Entertainment or other hospitality, and any gifts offered to members of the medical and allied professions, should be secondary to the main purpose of the meeting and should be kept to a modest level.

24. Any support to individual health practitioners to participate in any domestic or international symposia should not be conditional upon any obligation to promote any medicinal product.

to previous section to next section
 

Last updated: May 3, 2013